MATTHEW PITERA: Open Payments
NPI 1225097702 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,622 in 35 payments from 10 companies in 2025. Trend: 2023 $35,012 · 2024 $14,903 · 2025 $9,622
Speaker / faculty: $9,000Food & beverage: $513Travel & lodging: $84Education: $25
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $9,192 |
| Supernus Pharmaceuticals, Inc. | 9 | $188 |
| Axsome Therapeutics, Inc. | 5 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Almatica Pharma LLC | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Tris Pharma Inc | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
Products named: VRAYLAR, Qelbree, Auvelity, REXULTI, COBENFY, CAPLYTA, LOREEV XR, Azstarys.
Industry payments across NJ — which companies pay providers there.
